Hope on the horizon: how pegbelfermin offers a glimmer of hope for NASH sufferers?

Authors

  • Sawairah Mukhtiar 5th Year MBBS Student, Dow International Medical College, Karachi, Pakistan
  • Nisha Babar 5th Year MBBS Student, Dow International Medical College, Karachi, Pakistan
  • Fatima Rehan 5th Year MBBS Student, Dow International Medical College, Karachi, Pakistan

DOI:

https://doi.org/10.47391/JPMA.9769

Abstract

Madam,

Non-alcoholic steatohepatitis (NASH), is described as having hepatic steatosis of >5%, inflammation, and hepatocyte damage (such as ballooning), including or excluding fibrosis¹. NASH falls under a group of liver diseases termed Non-alcoholic Fatty Liver Disease (NAFLD) varying from benign steatosis to inflammatory NASH and hepatic fibrosis.

---Continue

Downloads

Published

2023-11-28

How to Cite

Mukhtiar, S., Nisha Babar, & Fatima Rehan. (2023). Hope on the horizon: how pegbelfermin offers a glimmer of hope for NASH sufferers?. Journal of the Pakistan Medical Association, 73(12), 2526–2527. https://doi.org/10.47391/JPMA.9769

Issue

Vol. 73 No. 12 (2023): DECEMBER

Section

LETTER TO THE EDITOR

License

Copyright (c) 2023 Journal of the Pakistan Medical Association

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.